K210287 is an FDA 510(k) clearance for the VITEK 2 AST- Streptococcus Cefotaxime (<=0.125 - =>8 ug/mL). This device is classified as a System, Test, Automated, Antimicrobial Susceptibility, Short Incubation (Class II - Special Controls, product code LON).
Submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on October 28, 2021, 268 days after receiving the submission on February 2, 2021.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1645.
| 510(k) Number | K210287 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | February 02, 2021 |
| Decision Date | October 28, 2021 |
| Days to Decision | 268 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | LON — System, Test, Automated, Antimicrobial Susceptibility, Short Incubation |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 866.1645 |